700103 | cholest-4-en-3-one-d7
cholest-4-en-3-one-d7
cholest-4-en-3-one-d7
cholest-4-en-3-one-d7
Cholest-4-en-3-one-d7 is a deuterated form of cholest-4-en-3-one, meaning that a hydrogen atom has been replaced with a deuterium atom - deuterium is one of the two heavy and stable isotopes of hydrogen.
Cholest-4-en-3-one is a cholest-4-ene substituted by an oxo- group at the 3rd position. It’s a cholestanoid and a human and plant metabolite. The compound is derived from cholesterol as a result of cholesterol oxidation and isomerization, processes catalyzed by cholesterol oxidase - a bacterial flavoenzyme.
Cholest-4-en-3-one acts as an important synthetic intermediate detergent in various steroid transformations.
Studies show promising evidence that the metabolite has potent effects against obesity, liver disease, and keratinization.
Cholest-4-en-3-one is also found to play a role as a precursor in the production of drug intermediates, including androsta-1,4-diene-3,17-dione or androst-4-ene-3,17-dione, which are crucial starting resources for the synthesis of anabolic drugs and contraceptive hormones.
The cholestanoid has some derivatives, like the new developing drug Olesoxime (cholest-4-en-3-one, oxime) that displays neuroprotective properties in the therapy of spinal muscular atrophy.
The isotope-labeled variation of the cholesterol derivative, Cholest-4-en-3-one-d7 is intended for use as an internal standard for the quantification of cholest-4-en-3-one.
Avanti Research synthesizes high-grade Cholest-4-en-3-one-d7 to support science laboratories and research projects worldwide.
C27H37D7O
C 82.79%, H 13.12%, O 4.08%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by Bioz- Certificate of Analysis (Lot No. 700103P-1MG-A-010 and 6894PGA010)
